PROACT: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interventions
- Institution
- FRED HUTCHINSON CANCER CENTER, WA
- Principal investigator
- Rachel B. Issaka
- Funding
- $621K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
Project Summary/Abstract Colorectal cancer (CRC) deaths have continuously decreased since the early 1990's, yet populations that receive care in safety-net healthcare systems, which represent 25% of all U.S. hospitals, have relatively poorer CRC-related outcomes compared to their counterparts. Safety-net healthcare systems disproportionately care for lower socioeconomic status individuals, minoritized groups, and other populations with high CRC-mortality due to lack of access to care. Fecal immunochemical test (FIT) is preferred for CRC screening in safety-net healthcare systems due to low-cost and ease of completion, however only 33% to 58% of patients in safety-net healthcare systems complete a follow-up colonoscopy within 1 year of an abnormal FIT. This failure to follow- up carries a 3-fold increased risk of advanced-stage CRC and a 2-fold increased risk of dying from CRC. Greater than 6-month delays in follow-up colonoscopy are associated with an increased risk of any CRC and advanced stage CRC. Previous research has shown that obtaining a follow-up colonoscopy is a complex process for safety-net patients due to multiple barriers at multiple levels of care, including lack of transportation, fear of colonoscopy, and fragmented care in a resource-constrained health system. To address these barriers, our project aims to evaluate a multilevel intervention for follow-up colonoscopy in a safety-net healthcare system compared to usual care. This study takes advantage of several single-level interventions that have been developed, tested and implemented at Harborview Medical Center (HMC) and Kent/Des Moines (KDM) clinic, safety net health settings in Seattle, WA. These interventions include: 1) a health system- level centralized CRC program aimed to improve screening and follow-up colonoscopy, 2) a health system- level navigation to follow-up colonoscopy program, 3) a patient-level rideshare program to address transportation barriers; and 4) a patient-level video to reduce fear of colonoscopy. We propose to evaluate these interventions together as a novel, multilevel intervention that addresses multiple barriers to follow-up colonoscopy at the patient- and health system-level versus usual care (centralized CRC screening and navigation to colonoscopy). Our central hypothesis is that a multilevel intervention that addresses multiple patient- and health system-level barriers simultaneously, will significantly increase the proportion of patients who receive a follow-up colonoscopy, compared to usual care, and will be possible to implement in a safety-net setting. To test our hypothesis, we will conduct a pragmatic randomized controlled trial of HMC and KDM safety-net patients with abnormal FIT results, randomized 1:1 to the multilevel intervention vs usual care. Our specific aims are: 1) Assess the effectiveness of the multilevel intervention at improving follow-up colonoscopy completion in a safety-net population compared to a health system-level only intervention (usual care); 2) Evaluate the facilitators and barriers to the reach, acceptability, fidelity and implementation of the multilevel intervention; and 3) Evaluate the cost of implementing the multilevel intervention in a safety-net population.
LOADING MOONBASE SCORE
Questions for FRED HUTCHINSON CANCER CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Fred Hutchinson Cancer Center50
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)
Stephanie J Lee · $877K · 2020–2026
- NIH · Fred Hutchinson Cancer Center47
Forecasting influenza evolution on a heterogeneous immune landscape
Trevor Bc Bedford · $744K · 2022–2028
- NIH · Fred Hutchinson Cancer Center43
Role of tumor cell cluster-induced signaling in breast cancer metastasis
Kevin Jon Cheung · $403K · 2024–2026